NCT06513585View on ClinicalTrials.gov

Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy

NARecruitingINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions
Primary AldosteronismSuprarenalectomySuper Selective Adrenal Artery Embolization
Interventions
PROCEDURE

Superselective adrenal artery embolization or adrenalectomy

Arm A underwent SAAE treatment, and arm B underwent laparoscopic adrenalectomy.

Trial Locations (1)

630000

RECRUITING

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
collaborator

First Affiliated Hospital of Xinjiang Medical University

OTHER

lead

Xinjiang Medical University

OTHER